Why Cellect Biotechnology Stock Is Skyrocketing Today

Cellect Biotechnology (NASDAQ: APOP), an Israeli-based stem-cell company, today announced the first successful stem cell transplant procedure using its ApoGraft technology in a combined phase 1/2 clinical trial in a blood cancer patient, causing its shares to rise by as much as 115%. The company's stock has since cooled off, but is still up by 80% as of 3:00 p.m.

BING NEWS:
  • Which Is a Better Investment, Celldex Therapeutics, Inc. or BIO-TECHNE Corp Stock?
    Learn more about whether Celldex Therapeutics, Inc. or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
    04/19/2024 - 2:08 am | View Link
  • We Need to be Ready for Biotechnology’s “ChatGPT” Moment
    Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes .
    04/16/2024 - 9:20 am | View Link
  • Why NextPlat Shares Are Skyrocketing Today
    NextPlat Corp (NASDAQ:NXPL) shares are skyrocketing on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc. According ...
    04/12/2024 - 3:45 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News